AU1700688A - Sulfinyl and sulfonyl substituted 3-benzazepines - Google Patents

Sulfinyl and sulfonyl substituted 3-benzazepines

Info

Publication number
AU1700688A
AU1700688A AU17006/88A AU1700688A AU1700688A AU 1700688 A AU1700688 A AU 1700688A AU 17006/88 A AU17006/88 A AU 17006/88A AU 1700688 A AU1700688 A AU 1700688A AU 1700688 A AU1700688 A AU 1700688A
Authority
AU
Australia
Prior art keywords
benzazepines
sulfinyl
sulfonyl substituted
sulfonyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17006/88A
Inventor
William Edward Bondinell
Herbert Stowell Ormsbee Iii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/167,663 external-priority patent/US4824839A/en
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU1700688A publication Critical patent/AU1700688A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU17006/88A 1987-04-09 1988-04-04 Sulfinyl and sulfonyl substituted 3-benzazepines Abandoned AU1700688A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3640387A 1987-04-09 1987-04-09
US036403 1987-04-09
US07/167,663 US4824839A (en) 1985-12-20 1988-03-14 Sulfinyl and sulfonyl substituted 2,3,4,5 tetrahydro-1H-3-benzazepines and their use in treating gastrointestinal motility disorders
US167663 1998-10-07

Publications (1)

Publication Number Publication Date
AU1700688A true AU1700688A (en) 1988-11-04

Family

ID=26713145

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17006/88A Abandoned AU1700688A (en) 1987-04-09 1988-04-04 Sulfinyl and sulfonyl substituted 3-benzazepines

Country Status (2)

Country Link
AU (1) AU1700688A (en)
WO (1) WO1988007858A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
SI2332921T1 (en) 2003-06-17 2016-06-30 Arena Pharmaceuticals, Inc. 8-Chloro-1 -methyl-2,3,4,5-tetrahydro-1 H-3benzazapine Hydrochloride
AU2004253888B2 (en) 2003-06-17 2010-11-11 Arena Pharmaceuticals, Inc. Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
WO2006069363A2 (en) 2004-12-21 2006-06-29 Arena Pharmaceuticals, Inc. Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
WO2006071740A2 (en) 2004-12-23 2006-07-06 Arena Pharmaceuticals, Inc. 5ht2c receptor modulator compositions and methods of use
EP2471779A1 (en) 2006-04-03 2012-07-04 Arena Pharmaceuticals, Inc. Process for the resolution of a mixture of (R)- and (S)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
WO2008070111A2 (en) 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
CN102015591B (en) 2008-03-04 2014-01-29 艾尼纳制药公司 Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-choro-i-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
KR20130112848A (en) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. Processes for the preparation of 5-ht2c receptor agonists
CA3050049A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-ht2c agonists useful for weight management
AU2011296033A1 (en) 2010-09-01 2013-04-04 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-HT2C agonists
MX2013002422A (en) 2010-09-01 2013-05-17 Arena Pharm Inc Salts of lorcaserin with optically active acids.
WO2012030939A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Administration of lorcaserin to individuals with renal impairment
AR088670A1 (en) 2012-10-09 2014-06-25 Arena Pharm Inc WEIGHT CONTROL METHOD

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3689649A (en) * 1970-07-16 1972-09-05 Henri Dietrich N-substituted n-arylsulfonyl ureas for producing a hypoglycaemic effect
CH593263A5 (en) * 1974-02-22 1977-11-30 Hoffmann La Roche

Also Published As

Publication number Publication date
WO1988007858A1 (en) 1988-10-20

Similar Documents

Publication Publication Date Title
AU2796489A (en) Voice/data switch
AU614965B2 (en) Thiadiazinones
AU1033188A (en) Connecting devices
AU2132388A (en) Airbridge
AU1407388A (en) Substituted di-t-butylphenols
AU2222388A (en) Peptidylheterocycles
AU1381888A (en) Timeswitches
AU1700688A (en) Sulfinyl and sulfonyl substituted 3-benzazepines
AU1301788A (en) Chemo-radio-immuno-conjugates
AU1289588A (en) Hinge joint
AU1388788A (en) Pivot joint
AU1764488A (en) Substituted 5-methylamino-1-arylpyrazoles
AU1263488A (en) Pivot joint
AU2006288A (en) 1-Arylpyrazoles
AU2102988A (en) 1-arylpyrazoles
AU2665388A (en) 17-methylene-and 17-ethylidene-estratrienes
AU625634B2 (en) Pivot joint
AU1533288A (en) Pivot joint
AU1313888A (en) Pivot joint
AU2586688A (en) Moth- and beetle-proofing agents
AU1158888A (en) Scraper-spreader
AU1366388A (en) Videosystem
AU1186388A (en) Trocar
AU1747588A (en) Hinge devices
AU2611888A (en) Substituted quinolines